Evidence map›Paper›PMID 39640355›Full record

ArticleSurgical neurology international2024

A rare case of spinal myeloid sarcoma.

Wouter Deconinck, Sven Bamps, Thomas Steelandt, Maarten Wissels, Mark Plazier, Eric Put, Salah-Eddine Achahbar, Steven Vanvolsem, Sacha Meeuws, Sam Klein and 1 more

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Primary isolated lumbar spine myeloid sarcoma: a rare case report and review of the literature.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wouter DeconinckDepartment of Neurosurgery, Jessa Hospital, Hasselt, Belgium.
Sven BampsDepartment of Neurosciences, Faculty of Medicine, University of Hasselt, Hasselt, Belgium.
Thomas SteelandtDepartment of Pathology, Jessa Hospital, Hasselt, Belgium.
Maarten WisselsLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Mark PlazierDepartment of Neurosciences, Faculty of Medicine, University of Hasselt, Hasselt, Belgium.
Eric PutLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Salah-Eddine AchahbarLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Steven VanvolsemLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Sacha MeeuwsLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Sam KleinLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.
Gert RoosenLimburg Clinical Research Centre (LCRC), University of Hasselt, Hasselt, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Myeloid sarcoma (MS), a rare extramedullary tumor composed of myeloid blast cells, is classified by the World Health Organization as a subtype of acute myeloid leukemia (AML). Isolated, primary, or nonleukemic MS has an incidence of 2/1,000,000 adults and constitutes only 0.7% of all AML cases. MS presentations vary widely, with spinal involvement being rare. Case Description: A-year-old male presented with interscapular pain radiating to the right upper arm/neck but was neurologically intact. Once diagnosed with isolated spinal MS, he underwent a surgical decompression followed by local irradiation, systemic chemotherapy, and bone marrow transplantation. Eight months postoperatively, however, he experienced a graft-versus-host rejection and required additional therapies. Conclusion: Establishing the diagnosis of MS is challenging and typically requires histological confirmation (i.e., the presence of myeloblasts and granulocytic cells). However, optimal treatment strategies remain elusive; despite radiation, chemotherapy, bone marrow transplant/other local therapies, the overall long-term prognosis for MS remains poor.

Indexed as

Compression fractureMyeloid sarcomaPolycythemia veraSpinal tumorThoracic spine

Identifiers

PMID39640355
PMCPMC11618787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.